# Expanded Generic Eye Treatments Upsher-Smith Introduces Two Strengths of Brimonidine Eye Drops By Mursal Rahman | Written with AI assistance | Published 2026-11-10 | Lifestyle Source: Trend Hunter, https://www.trendhunter.com/trends/expanded-generic-eye-treatments References: [prnewswire](https://www.prnewswire.com/news-releases/upsher-smith-launches-two-strengths-of-brimonidine-tartrate-ophthalmic-solution-302933535.html)  Expanded generic eye treatments are becoming available as Upsher-Smith Laboratories introduces two concentrations of Brimonidine Tartrate Ophthalmic Solution. The launch adds 0.1% and 0.15% formulations to the company's pharmaceutical offerings, providing additional options corresponding to the branded medication ALPHAGAN P. Both concentrations are available in 5 mL, 10 mL, and 15 mL quantities, allowing pharmaceutical customers to select from multiple packaging configurations. The 0.1% formulation carries an AB therapeutic equivalence rating, while the 0.15% version has an AT designation. These classifications identify how the products are evaluated against their reference medication. For Upsher-Smith, the expanded selection creates opportunities to strengthen its position in the U.S. ophthalmic pharmaceutical market. According to IQVIA figures cited by the company, the market for these concentrations generated approximately $115 million in U.S. sales between September 2025 and August 2026. Image Credit: Upsher-Smith Laboratories, LLC ## Trend Insights (Trend Hunter) - Score: 4.2/10 - Popularity: 15% | Activity: 12% | Freshness: 99% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Lifestyle](https://www.trendhunter.com/lifestyle) > [Health](https://www.trendhunter.com/health) ## Key Themes ### Why This Trend Is Growing - **Generic Ophthalmic Expansion:** Broader availability of equivalent eye medications is reshaping treatment access by creating space for lower-cost alternatives to branded ophthalmic therapies. - **Multi-strength Formulations:** Multiple dosage strengths in established drug categories support more tailored prescribing patterns and differentiated product positioning in competitive generics markets. - **Flexible Pharma Packaging:** Varied bottle sizes in ophthalmic products reflect growing demand for inventory flexibility, patient convenience, and channel-specific dispensing strategies. ### Industries Being Reshaped - **Generic Pharmaceuticals:** Patent-expired specialty medications present recurring opportunities for manufacturers to capture value through equivalent formulations and competitive pricing. - **Ophthalmic Care:** Eye-care treatment markets are evolving as expanded medication choices improve accessibility for chronic conditions such as glaucoma and ocular hypertension. - **Pharmaceutical Distribution:** Diverse package configurations create new efficiencies for wholesalers, pharmacies, and healthcare providers managing demand across patient and institutional settings. ## Related on Trend Hunter - [Age-Related Ocular Degeneration Drops](https://www.trendhunter.com/trends/tenpoint-yuvezzi.md) - [Targeted Prescription-Based Kits](https://www.trendhunter.com/trends/primera-professional-pharmacy.md) - [Rapid Redness Relief Drops](https://www.trendhunter.com/trends/rapid-redness-relief-drops.md) - [Oral Lung-Disease Tablets](https://www.trendhunter.com/trends/oral-lung-disease-tablets.md) - [Preservative-Free Eye Drops](https://www.trendhunter.com/trends/similasan-eye-drops.md) - [Age-Related Vision Treatments](https://www.trendhunter.com/trends/age-related-vision-treatments.md) - [Generic Pulmonary Hypertension Drugs](https://www.trendhunter.com/trends/generic-pulmonary-hypertension-tablets.md) - [Multi-Action Dry Eye Drops](https://www.trendhunter.com/trends/eyes-for-hours.md) - [Extended-Release Pain Medications](https://www.trendhunter.com/trends/extended-release-pain-medications.md)